AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26084590 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept continuous regimen
Number of subjects: 54
Study 23289453 — intervention group
Group type: EXPERIMENTAL
Intervention: Central venous catheter (CVC) samples of vancomycin or tobramycin
Number of subjects: 50
Study 23289453 — intervention group
Group type: COMPARATOR
Intervention: Peripheral vein samples of vancomycin or tobramycin
Number of subjects: 50
Study 20667993 — intervention group
Group type: EXPERIMENTAL
Intervention: Belatacept
Number of subjects: 0
Study 20667993 — intervention group
Group type: COMPARATOR
Intervention: CNI
Number of subjects: 0
Study 19583712 — intervention group
Group type: COMPARATOR
Intervention: Colposcopic examination only
Number of subjects: 929
Study 19583712 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical punch biopsies
Number of subjects: 929
Study 19583712 — intervention group
Group type: EXPERIMENTAL
Intervention: Large loop excision of the transformation zone (LLETZ)
Number of subjects: 929
Study 17080277 — intervention group
Group type: EXPERIMENTAL
Intervention: Perianal local anesthesia (40 ml of ropivacaine, 4.75 mg/ml, plus 15 ml of ropivacaine, 2 mg/ml)
Number of subjects: 33
Study 17080277 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 33
Study 17080277 — intervention group
Group type: EXPERIMENTAL
Intervention: Perianal local anesthesia
Number of subjects: 33
Study 14971717 — intervention group
Group type: EXPERIMENTAL
Intervention: Flavonoid extract (Colladeen, 320 mg oligomeric procyanidins)
Number of subjects: 30
Study 14971717 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 11352620 — intervention group
Group type: EXPERIMENTAL
Intervention: Task-oriented arm training
Number of subjects: 10
Study 11352620 — intervention group
Group type: COMPARATOR
Intervention: Passive movements (Control)
Number of subjects: 10
Study 10186469 — intervention group
Group type: EXPERIMENTAL
Intervention: Ribosomal vaccine (Ribomunyl)
Number of subjects: 327
Study 10186469 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 327
Study 8313547 — intervention group
Group type: EXPERIMENTAL
Intervention: Ridogrel
Number of subjects: 907
Study 8313547 — intervention group
Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 907
Study 2968060 — intervention group
Group type: EXPERIMENTAL
Intervention: Loratadine 10 mg
Number of subjects: 29
Study 2968060 — intervention group
Group type: EXPERIMENTAL
Intervention: Loratadine 20 mg
Number of subjects: 29
Study 2968060 — intervention group
Group type: EXPERIMENTAL
Intervention: Loratadine 40 mg
Number of subjects: 29
Study 2968060 — intervention group
Group type: EXPERIMENTAL
Intervention: Loratadine 80 mg
Number of subjects: 29
Study 2968060 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 29671069 — intervention group
Group type: EXPERIMENTAL
Intervention: MYL-1401H
Number of subjects: 0
Study 29671069 — intervention group
Group type: COMPARATOR
Intervention: Reference pegfilgrastim (Neulasta® sourced from the EU)
Number of subjects: 0
Study 29671069 — intervention group
Group type: COMPARATOR
Intervention: Reference pegfilgrastim (sourced from the USA)
Number of subjects: 0
Study 27680990 — intervention group
Group type: EXPERIMENTAL
Intervention: Açai-based smoothie (AS)
Number of subjects: 23
Study 27680990 — intervention group
Group type: COMPARATOR
Intervention: Macronutrient-matched control smoothie (PS)
Number of subjects: 23
Study 26111954 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent intervention delivered over two training sessions and a follow-up telephone call
Number of subjects: 107
Study 26111954 — intervention group
Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 107
Study 23982208 — intervention group
Group type: EXPERIMENTAL
Intervention: BIS monitoring during balanced propofol sedation
Number of subjects: 115
Study 23982208 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard monitoring)
Number of subjects: 115
Study 21422465 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialogic argumentation intervention
Number of subjects: 0
Study 21422465 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (extensive essay writing practice and whole-class discussion)
Number of subjects: 0
Study 18310201 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunflower seed oil
Number of subjects: 497
Study 18310201 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquaphor ointment
Number of subjects: 497
Study 18310201 — intervention group
Group type: COMPARATOR
Intervention: Control group (no emollient therapy)
Number of subjects: 497
Study 16698259 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium
Number of subjects: 921
Study 16698259 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 921
Study 12823564 — intervention group
Group type: EXPERIMENTAL
Intervention: New antiepileptic drugs (AEDs) in monotherapy
Number of subjects: 0
Study 12823564 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 10797177 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolysis treatment
Number of subjects: 4342
Study 8884400 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous sumatriptan (6 mg)
Number of subjects: 19
Study 8884400 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 8396000 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed thoracic radiotherapy (mean 46.5 Gy-equivalent)
Number of subjects: 53
Study 8396000 — intervention group
Group type: COMPARATOR
Intervention: No treatment until relapse
Number of subjects: 53
Study 3714767 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine sulfate 2 mg/70 kg
Number of subjects: 10
Study 3714767 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine sulfate 4 mg/70 kg
Number of subjects: 10
Study 29778856 — intervention group
Group type: EXPERIMENTAL
Intervention: Global longitudinal strain (GLS) using 3 apical views
Number of subjects: 108
Study 29778856 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-chamber longitudinal strain (4CV_LS)
Number of subjects: 108
Study 29778856 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-chamber longitudinal strain (2CV_LS)
Number of subjects: 108
Study 29778856 — intervention group
Group type: EXPERIMENTAL
Intervention: Global longitudinal strain (GLS)
Number of subjects: 108
Study 29778856 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-view LS measurements (4CV_LS and 2CV_LS)
Number of subjects: 108
Study 27476586 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal prehabilitation program
Number of subjects: 106
Study 27476586 — intervention group
Group type: COMPARATOR
Intervention: Control group (higher fitness)
Number of subjects: 106
Study 24610413 — intervention group
Group type: EXPERIMENTAL
Intervention: Royal jelly supplementation (1,000 mg daily for 8 weeks)
Number of subjects: 50
Study 24610413 — intervention group
Group type: COMPARATOR
Intervention: Placebo (for 8 weeks)
Number of subjects: 50
Study 23858423 — intervention group
Group type: EXPERIMENTAL
Intervention: Foam plastic insert
Number of subjects: 78
Study 23858423 — intervention group
Group type: COMPARATOR
Intervention: No insert (Control)
Number of subjects: 78
Study 21416590 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive computer program (IC)
Number of subjects: 44
Study 21416590 — intervention group
Group type: COMPARATOR
Intervention: Standard one-on-one genetic counseling
Number of subjects: 44
Study 18332408 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic forms on handheld computers
Number of subjects: 60
Study 18332408 — intervention group
Group type: COMPARATOR
Intervention: Paper forms
Number of subjects: 60
Study 16981875 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormonal contraceptive intake phase
Number of subjects: 8
Study 16981875 — intervention group
Group type: COMPARATOR
Intervention: HC washout week
Number of subjects: 8
Study 14609896 — intervention group
Group type: EXPERIMENTAL
Intervention: BD QuikHeel lancet (QH)
Number of subjects: 80
Study 14609896 — intervention group
Group type: COMPARATOR
Intervention: BD Safety-Flow lancet (SF)
Number of subjects: 80
Study 10761763 — intervention group
Group type: EXPERIMENTAL
Intervention: Fludarabine (Flu) 25 mg/m2 for five consecutive days every four weeks
Number of subjects: 60
Study 10761763 — intervention group
Group type: EXPERIMENTAL
Intervention: Cladribine (CdA) 0.14 mg/kg for five consecutive days every four weeks
Number of subjects: 60
Study 10761763 — intervention group
Group type: COMPARATOR
Intervention: Cladribine (CdA)
Number of subjects: 60
Study 10761763 — intervention group
Group type: COMPARATOR
Intervention: Fludarabine (Flu)
Number of subjects: 60
Study 10761763 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-over treatment after failure
Number of subjects: 60
Study 8848318 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional neuromuscular stimulation (FNS) hand system
Number of subjects: 5
Study 8848318 — intervention group
Group type: COMPARATOR
Intervention: Tenodesis
Number of subjects: 5
Study 1407981 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical medication and/or laser trabeculoplasty
Number of subjects: 30
Study 1407981 — intervention group
Group type: EXPERIMENTAL
Intervention: Fistulizing surgery
Number of subjects: 30
Study 1407981 — intervention group
Group type: COMPARATOR
Intervention: No therapy (control group)
Number of subjects: 30
Study 6726903 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative radiation therapy (1,600 rad for 4 days)
Number of subjects: 197
Study 6726903 — intervention group
Group type: COMPARATOR
Intervention: Contemporary surgery without preoperative radiation therapy
Number of subjects: 197
Study 31285924 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar transurethral resection (B‐TURBT)
Number of subjects: 80
Study 31285924 — intervention group
Group type: COMPARATOR
Intervention: Monopolar transurethral resection (M‐TURBT)
Number of subjects: 80
Study 30509743 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 μg/kg oral morphine sulphate
Number of subjects: 31
Study 30509743 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 27063315 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed Twin-Block combined with fixed appliance
Number of subjects: 31
Study 27063315 — intervention group
Group type: COMPARATOR
Intervention: Fixed appliance after tooth extraction
Number of subjects: 31
Study 24856057 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin nasal spray (20 international units)
Number of subjects: 136
Study 24856057 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136
Study 23768677 — intervention group
Group type: EXPERIMENTAL
Intervention: STOP IT program (integrated treatment for PTSD and smoking)
Number of subjects: 6
Study 20805642 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous methylprednisolone
Number of subjects: 133
Study 20805642 — intervention group
Group type: COMPARATOR
Intervention: Control (no intravenous methylprednisolone)
Number of subjects: 133
Study 18493088 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheelchair (WCL)
Number of subjects: 113
Study 18493088 — intervention group
Group type: COMPARATOR
Intervention: Able-bodied (ABL)
Number of subjects: 113
Study 15928250 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA (100 mg/d)
Number of subjects: 15
Study 15928250 — intervention group
Group type: EXPERIMENTAL
Intervention: APZ (0.5 mg)
Number of subjects: 15
Study 15928250 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA and APZ in combination
Number of subjects: 15
Study 12181240 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-FU plus cisplatin (FUP) - continuous 5-FU 1000 mg/m2/day for 5 days plus cisplatin 100 mg/m2 on day 1 or day 2
Number of subjects: 207
Study 12181240 — intervention group
Group type: COMPARATOR
Intervention: 5-FU (FU) - 5-FU 500 mg/m2/day for 5 days
Number of subjects: 207
Study 12181240 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-FU plus cisplatin (FUP)
Number of subjects: 207
Study 12181240 — intervention group
Group type: COMPARATOR
Intervention: 5-FU (FU)
Number of subjects: 207
Study 10600332 — intervention group
Group type: EXPERIMENTAL
Intervention: ALLERVAX CAT (750 microg/dose)
Number of subjects: 133
Study 10600332 — intervention group
Group type: EXPERIMENTAL
Intervention: ALLERVAX CAT
Number of subjects: 133
Study 10600332 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 133
Study 8635183 — intervention group
Group type: EXPERIMENTAL
Intervention: L-deprenyl (10 mg daily) as an adjunct to low-dose bromocriptine (up to 25 mg daily)
Number of subjects: 21
Study 8635183 — intervention group
Group type: COMPARATOR
Intervention: Bromocriptine alone
Number of subjects: 21
Study 8635183 — intervention group
Group type: COMPARATOR
Intervention: Bromocriptine plus placebo
Number of subjects: 21
Study 8635183 — intervention group
Group type: EXPERIMENTAL
Intervention: L-deprenyl plus bromocriptine
Number of subjects: 21
Study 2126361 — intervention group
Group type: EXPERIMENTAL
Intervention: GHRH (1 microgram/kg BW in an i.v. bolus)
Number of subjects: 14
Study 2126361 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (150 micrograms in a single oral dose)
Number of subjects: 14
Study 2126361 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin (0.15 IU/kg BW in an i.v. bolus)
Number of subjects: 14
Study 2126361 — intervention group
Group type: EXPERIMENTAL
Intervention: TRH (200 micrograms in an i.v. bolus)
Number of subjects: 14
Study 2126361 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control test)
Number of subjects: 14
Study 832432 — intervention group
Group type: COMPARATOR
Intervention: NaCl supplements of 200 mEq/day
Number of subjects: 6
Study 832432 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily mixture of NaHCO3 (100 mEq) and NaCl (100 mEq)
Number of subjects: 6
Study 832432 — intervention group
Group type: EXPERIMENTAL
Intervention: NaHCO3
Number of subjects: 6
Study 31834062 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist-guided online F-PST
Number of subjects: 150
Study 31834062 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-guided online F-PST
Number of subjects: 150
Study 31834062 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face F-PST
Number of subjects: 150
Study 30723316 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram (dose-dependent)
Number of subjects: 0
Study 30723316 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram (high dose)
Number of subjects: 0
Study 30723316 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram (low dose)
Number of subjects: 0
Study 28723597 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra tympanic Gentamicin (40 mgs/ml)
Number of subjects: 60
Study 28723597 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra tympanic Dexamethasone (0.5 ml, 4 mgs/ml)
Number of subjects: 60
Study 28723597 — intervention group
Group type: COMPARATOR
Intervention: Intra tympanic Normal Saline (0.5 ml)
Number of subjects: 60
Study 26036257 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey extensively hydrolysed formulas (eHF)
Number of subjects: 150
Study 26036257 — intervention group
Group type: EXPERIMENTAL
Intervention: Casein extensively hydrolysed formulas (eHF)
Number of subjects: 150
Study 26036257 — intervention group
Group type: EXPERIMENTAL
Intervention: Amino acid-based formulas (AAFs)
Number of subjects: 150
Study 26036257 — intervention group
Group type: COMPARATOR
Intervention: Cow's milk
Number of subjects: 150
Study 23942156 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief mindfulness induction
Number of subjects: 63
Study 23942156 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 63
Study 22193396 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary delivery of 100 million bone marrow mononuclear cells (BMMC) through the anterograde route (IAC)
Number of subjects: 30
Study 22193396 — intervention group
Group type: COMPARATOR
Intervention: Retrograde intravenous delivery of 100 million bone marrow mononuclear cells (BMMC) through the IVC route
Number of subjects: 30
Study 19807950 — intervention group
Group type: EXPERIMENTAL
Intervention: iPod users
Number of subjects: 30
Study 19807950 — intervention group
Group type: COMPARATOR
Intervention: Conference attendees
Number of subjects: 30
Study 16331696 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial access (RA) during coronary angiograms
Number of subjects: 297
Study 16331696 — intervention group
Group type: COMPARATOR
Intervention: Femoral access (FA) during coronary angiograms
Number of subjects: 297
Study 16331696 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial access (RA) during coronary interventions
Number of subjects: 297
Study 16331696 — intervention group
Group type: COMPARATOR
Intervention: Femoral access (FA) during coronary interventions
Number of subjects: 297
Study 15187836 — intervention group
Group type: EXPERIMENTAL
Intervention: Reamed nailing
Number of subjects: 82
Study 15187836 — intervention group
Group type: COMPARATOR
Intervention: Nonreamed nailing
Number of subjects: 82
Study 11040903 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital colour photography
Number of subjects: 37
Study 11040903 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral fluorescein angiography (OFA)
Number of subjects: 37
Study 11040903 — intervention group
Group type: COMPARATOR
Intervention: Standard seven-field stereo photography (gold standard)
Number of subjects: 37
Study 9074574 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression stockings
Number of subjects: 194
Study 9074574 — intervention group
Group type: COMPARATOR
Intervention: No stockings (control)
Number of subjects: 194
Study 8378945 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticlopidine 250 mg twice daily
Number of subjects: 0
Study 8378945 — intervention group
Group type: COMPARATOR
Intervention: Aspirin 650 mg twice daily
Number of subjects: 0
Study 3757511 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose regimen (400 mg/day RU 486 X 4 days or 200 mg/day X 4 days)
Number of subjects: 60
Study 3757511 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium dose regimen (100 mg/day X 7 days)
Number of subjects: 60
Study 3757511 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups (including both high and medium doses)
Number of subjects: 60
Study 29667507 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT)
Number of subjects: 30
Study 29667507 — intervention group
Group type: COMPARATOR
Intervention: Control group (breathing exercises)
Number of subjects: 30
Study 30285825 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible procedure for recruitment and retention of male prison leavers in trials
Number of subjects: 243
Study 30285825 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up interview 2-8 weeks after release
Number of subjects: 243
Study 30285825 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental health outcomes data collection at baseline and follow-up
Number of subjects: 243
Study 27323445 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (Zhongwan, Tianshu, Daheng, Daimai, Shuidao, Waiguan, Zulinqi with electroacupuncture stimulation at 2 Hz/100 Hz, 4‐8 mA for 20 min, once every other day for 8 weeks)
Number of subjects: 73
Study 27323445 — intervention group
Group type: COMPARATOR
Intervention: Health education (restraining wine or liquor and salt intake, stopping smoking, increasing physical activities, regular daily life habit)
Number of subjects: 73
Study 27323445 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 73
Study 24413724 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep hygiene training program (1 month, 6 sessions)
Number of subjects: 82
Study 24413724 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 82
Study 23342615 — intervention group
Group type: EXPERIMENTAL
Intervention: Silodosin 8 mg once daily for 12 weeks
Number of subjects: 955
Study 23342615 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg once daily for 12 weeks
Number of subjects: 955
Study 23342615 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 955
Study 23342615 — intervention group
Group type: EXPERIMENTAL
Intervention: Silodosin
Number of subjects: 955
Study 23342615 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin
Number of subjects: 955
Study 20687837 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg of arterolane once daily for 7 days
Number of subjects: 230
Study 20687837 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg of arterolane once daily for 7 days
Number of subjects: 230
Study 20687837 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg of arterolane once daily for 7 days
Number of subjects: 230
Study 18984430 — intervention group
Group type: EXPERIMENTAL
Intervention: Indapamide (IND) 2.5 mg once daily
Number of subjects: 23
Study 18984430 — intervention group
Group type: COMPARATOR
Intervention: Bendroflumethiazide (BDZ) 2.5 mg once daily
Number of subjects: 23
Study 18984430 — intervention group
Group type: EXPERIMENTAL
Intervention: Pooled data from both groups
Number of subjects: 23
Study 15836686 — intervention group
Group type: EXPERIMENTAL
Intervention: AAI-guided sevoflurane titration (target = 20 +/- 5)
Number of subjects: 100
Study 15836686 — intervention group
Group type: COMPARATOR
Intervention: Clinical signs-guided sevoflurane titration
Number of subjects: 100
Study 11918749 — intervention group
Group type: EXPERIMENTAL
Intervention: L-Arg supplementation (IV for three days)
Number of subjects: 54
Study 11918749 — intervention group
Group type: EXPERIMENTAL
Intervention: L-Arg administration
Number of subjects: 54
Study 11918749 — intervention group
Group type: COMPARATOR
Intervention: Control group (sham operated animals)
Number of subjects: 54
Study 10341399 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of maternal age, fetal nuchal translucency thickness, maternal serum free beta‐hCG, and PAPP‐A
Number of subjects: 1156
Study 10341399 — intervention group
Group type: COMPARATOR
Intervention: Nuchal translucency and maternal age alone
Number of subjects: 1156
Study 8730942 — intervention group
Group type: EXPERIMENTAL
Intervention: Dothiepin (150 mg/day)
Number of subjects: 87
Study 8730942 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study 8730942 — intervention group
Group type: EXPERIMENTAL
Intervention: Dothiepin
Number of subjects: 87
Study 1919421 — intervention group
Group type: EXPERIMENTAL
Intervention: Boiled coffee (BC)
Number of subjects: 20
Study 1919421 — intervention group
Group type: COMPARATOR
Intervention: Filtered boiled coffee (BFC)
Number of subjects: 20